mirabegron 50 MG 24 HR Extended Release Oral Tablet
- RxCUI
- 1300801
- RxNorm name
- mirabegron 50 MG 24 HR Extended Release Oral Tablet
- Display name
- mirabegron 50 MG 24 HR Extended Release Oral Tablet
- Full name
- mirabegron 50 MG 24 HR Extended Release Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:49
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MIRABEGRON | MIRABEGRON | REMEDYREPACK INC. | d0054db9-e38a-4786-be2c-996fa5b8f47d | 2026-05-22 | Warnings, Adverse reactions | 1300801 |
| Mirabegron | MIRABEGRON | Amneal Pharmaceuticals NY LLC | e597023d-6dcc-4d9e-8ce0-2d28a5d862f3 | 2026-03-26 | Warnings, Adverse reactions | 1300801 |
| MIRABEGRON | MIRABEGRON | Lupin Pharmaceuticals, Inc. | d22d3d12-8466-46db-bc19-d13e87c6115c | 2025-12-24 | Warnings, Adverse reactions | 1300801 |
| Mirabegron | MIRABEGRON | Qilu Pharmaceutical Co., Ltd. | 98247602-29b9-4621-8eeb-519e40b883b9 | 2025-10-21 | Warnings, Adverse reactions | 1300801 |
| Mirabegron | MIRABEGRON | REMEDYREPACK INC. | 5f7a1758-8691-4e53-96d6-a01626ee8140 | 2025-10-02 | Warnings, Adverse reactions | 1300801 |
| MIRABEGRON | MIRABEGRON | Bryant Ranch Prepack | 00826723-d25e-498a-b8d4-d17e5c14dda5 | 2025-09-26 | Warnings, Adverse reactions | 1300801 |
| MIRABEGRON | MIRABEGRON | Bryant Ranch Prepack | 1a7337a4-2901-4e65-b666-7623fadb78f2 | 2025-09-26 | Warnings, Adverse reactions | 1300801 |
| Mirabegron | MIRABEGRON | Zydus Lifesciences Limited | 461b2b94-205a-4860-9cb4-d30267ada9df | 2024-10-09 | Warnings, Adverse reactions | 1300801 |
| Mirabegron | MIRABEGRON | Zydus Pharmaceuticals (USA) Inc. | 2e40eb74-3b2a-47f7-bf31-fe27484f9bd2 | 2024-10-09 | Warnings, Adverse reactions | 1300801 |
| Myrbetriq | MIRABEGRON | Astellas Pharma US, Inc. | ba9e9e15-e666-4c56-9271-2e24739cfa2d | 2024-08-01 | Warnings, Adverse reactions | 1300801 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 00826723-d25e-498a-b8d4-d17e5c14dda5 | mirabegron 50 MG 24 HR Extended Release Oral Tablet | SY | 100 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20250926 |
| 00826723-d25e-498a-b8d4-d17e5c14dda5 | mirabegron 50 MG 24HR Extended Release Oral Tablet | PSN | 100 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20250926 |
| 00826723-d25e-498a-b8d4-d17e5c14dda5 | 24 HR mirabegron 50 MG Extended Release Oral Tablet | SCD | 100 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20250926 |
| 1a7337a4-2901-4e65-b666-7623fadb78f2 | 24 HR mirabegron 50 MG Extended Release Oral Tablet | SCD | 100 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20250926 |
| 1a7337a4-2901-4e65-b666-7623fadb78f2 | mirabegron 50 MG 24HR Extended Release Oral Tablet | PSN | 100 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20250926 |
| 1a7337a4-2901-4e65-b666-7623fadb78f2 | mirabegron 50 MG 24 HR Extended Release Oral Tablet | SY | 100 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20250926 |
| d22d3d12-8466-46db-bc19-d13e87c6115c | mirabegron 50 MG 24 HR Extended Release Oral Tablet | SY | 19 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20251224 |
| d22d3d12-8466-46db-bc19-d13e87c6115c | mirabegron 50 MG 24HR Extended Release Oral Tablet | PSN | 19 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20251224 |
| d22d3d12-8466-46db-bc19-d13e87c6115c | 24 HR mirabegron 50 MG Extended Release Oral Tablet | SCD | 19 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20251224 |
| ba9e9e15-e666-4c56-9271-2e24739cfa2d | mirabegron 50 MG 24 HR Extended Release Oral Tablet | SY | 17 | These highlights do not include all the information needed to use MYRBETRIQ ® /MYRBETRIQ ® GRANULES safely and effectively. See full prescribing information for MYRBETRIQ/MYRBETRIQ GRANULES. MYRBETRIQ (mirabegron extended-release tablets), for oral use MYRBETRIQ GRANULES (mirabegron for extended-release oral suspension) Initial U.S. Approval: 2012 | 20240801 |
| ba9e9e15-e666-4c56-9271-2e24739cfa2d | 24 HR mirabegron 50 MG Extended Release Oral Tablet | SCD | 17 | These highlights do not include all the information needed to use MYRBETRIQ ® /MYRBETRIQ ® GRANULES safely and effectively. See full prescribing information for MYRBETRIQ/MYRBETRIQ GRANULES. MYRBETRIQ (mirabegron extended-release tablets), for oral use MYRBETRIQ GRANULES (mirabegron for extended-release oral suspension) Initial U.S. Approval: 2012 | 20240801 |
| ba9e9e15-e666-4c56-9271-2e24739cfa2d | mirabegron 50 MG 24HR Extended Release Oral Tablet | PSN | 17 | These highlights do not include all the information needed to use MYRBETRIQ ® /MYRBETRIQ ® GRANULES safely and effectively. See full prescribing information for MYRBETRIQ/MYRBETRIQ GRANULES. MYRBETRIQ (mirabegron extended-release tablets), for oral use MYRBETRIQ GRANULES (mirabegron for extended-release oral suspension) Initial U.S. Approval: 2012 | 20240801 |
| e597023d-6dcc-4d9e-8ce0-2d28a5d862f3 | mirabegron 50 MG 24HR Extended Release Oral Tablet | PSN | 4 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20260326 |
| e597023d-6dcc-4d9e-8ce0-2d28a5d862f3 | mirabegron 50 MG 24 HR Extended Release Oral Tablet | SY | 4 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20260326 |
| e597023d-6dcc-4d9e-8ce0-2d28a5d862f3 | 24 HR mirabegron 50 MG Extended Release Oral Tablet | SCD | 4 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20260326 |
| 5f7a1758-8691-4e53-96d6-a01626ee8140 | mirabegron 50 MG 24 HR Extended Release Oral Tablet | SY | 3 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20251002 |
| 5f7a1758-8691-4e53-96d6-a01626ee8140 | mirabegron 50 MG 24HR Extended Release Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20251002 |
| 5f7a1758-8691-4e53-96d6-a01626ee8140 | 24 HR mirabegron 50 MG Extended Release Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20251002 |
| 2e40eb74-3b2a-47f7-bf31-fe27484f9bd2 | mirabegron 50 MG 24 HR Extended Release Oral Tablet | SY | 3 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20241009 |
| 2e40eb74-3b2a-47f7-bf31-fe27484f9bd2 | mirabegron 50 MG 24HR Extended Release Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20241009 |
| 2e40eb74-3b2a-47f7-bf31-fe27484f9bd2 | 24 HR mirabegron 50 MG Extended Release Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20241009 |
| 461b2b94-205a-4860-9cb4-d30267ada9df | 24 HR mirabegron 50 MG Extended Release Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20241009 |
| 461b2b94-205a-4860-9cb4-d30267ada9df | mirabegron 50 MG 24HR Extended Release Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20241009 |
| 461b2b94-205a-4860-9cb4-d30267ada9df | mirabegron 50 MG 24 HR Extended Release Oral Tablet | SY | 3 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20241009 |
| d0054db9-e38a-4786-be2c-996fa5b8f47d | mirabegron 50 MG 24 HR Extended Release Oral Tablet | SY | 1 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20260522 |
| d0054db9-e38a-4786-be2c-996fa5b8f47d | mirabegron 50 MG 24HR Extended Release Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20260522 |
| d0054db9-e38a-4786-be2c-996fa5b8f47d | 24 HR mirabegron 50 MG Extended Release Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20260522 |
| 98247602-29b9-4621-8eeb-519e40b883b9 | mirabegron 50 MG 24HR Extended Release Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20251021 |
| 98247602-29b9-4621-8eeb-519e40b883b9 | mirabegron 50 MG 24 HR Extended Release Oral Tablet | SY | 1 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20251021 |
| 98247602-29b9-4621-8eeb-519e40b883b9 | 24 HR mirabegron 50 MG Extended Release Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20251021 |